Plant-Based Endocannabinoid Modulation Without Psychoactive Effects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The legal and psychoactive limitations of cannabis-based treatments have hindered research and acceptance of the endocannabinoid system's health benefits, limiting the development of effective ECS-modulating therapies due to legal constraints and unwanted effects.
Innovation Solution
The use of non-cannabis, plant-based agents such as herbs and spices containing flavonoids to stimulate CB1 and CB2 receptors, inhibit cannabinoid uptake, and control the ratio of CB1 to CB2 receptor stimulation, mimicking the effects of cannabis without its legal and psychoactive issues, through precise dosing and formulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cannabis-based treatments are used to modulate the endocannabinoid system, then health benefits such as pain relief and appetite regulation are achieved, but legal constraints and unwanted psychoactive effects limit research and acceptance
Solution Approach 1:
The patent extracts the active pharmacological effects from cannabis by identifying and isolating specific non-cannabis plant compounds (such as curcumin from turmeric, capsaicin from chili peppers, and flavonoids from other plants) that can independently stimulate CB1 and CB2 receptors. This allows the therapeutic effects to be separated from the harmful legal and psychoactive associations with cannabis.
Solution Approach 2:
The patent introduces plant-based compounds as intermediary substances that mediate the interaction between the endocannabinoid system and external agents. These plant compounds (curcumin, capsaicin, flavonoids) serve as natural mediators that activate cannabinoid receptors without requiring cannabis, thereby avoiding legal and psychoactive issues while maintaining therapeutic effects.
2Reliability
If cannabis is used to treat various health problems, then therapeutic effects are achieved, but the association with cannabis politicizes the science and limits research funding
Solution Approach 1:
The patent extracts the scientific validity of cannabis-based treatments by identifying the specific receptor-stimulating properties that can be replicated using non-cannabis plant compounds. This allows the scientific community to study endocannabinoid system modulation without relying on cannabis, thereby maintaining research acceptance and funding independence.
Solution Approach 2:
The patent changes the chemical parameters by substituting cannabis compounds with alternative plant-based compounds that have similar pharmacological profiles. By changing the molecular identity while maintaining the functional effects (CB1 and CB2 receptor stimulation), the patent enables research to proceed without the political and legal complications associated with cannabis.
3Object-affected harmful factors
If non-cannabis plant-based agents are used to stimulate CB1 and CB2 receptors, then the legal and psychoactive drawbacks of cannabis are avoided, but precise dosing and formulations are required to achieve desired effects
Solution Approach 1:
The patent applies local quality by identifying specific plant compounds with distinct pharmacological properties and assigning them to specific therapeutic functions. Different plant-based agents (e.g., curcumin for inflammation, capsaicin for pain, flavonoids for neuroprotection) are selected and dosed according to their specific mechanisms and desired therapeutic outcomes, requiring precise formulation for each application.
Solution Approach 2:
The patent employs parameter changes by establishing specific dosage ranges and concentration levels for each plant-based compound to achieve optimal receptor stimulation. The patent defines precise formulation parameters (dosage, frequency, combination ratios) that must be carefully controlled to replicate the effects of cannabis while avoiding its harmful associations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the modulation of the endocannabinoid system to achieve a range of health and wellness effects, including pain relief, mood enhancement, and energy increase, without the legal and psychoactive drawbacks of cannabis, by leveraging common, readily available plant-based compounds.
Implementation Method 1
The use of non-cannabis, plant-based agents such as herbs and spices containing flavonoids to stimulate CB1 and CB2 receptors
Implementation Method 2
inhibit the uptake of the fatty acid amide hydrolase and monoacylgllycerol
Data Source
AI summary
Formulations and treatments are provided for selectively stimulating receptors of the endocannabinoid system (ECS). The formulations include non-cannabis, plant-based agents from readily available herbs, spices and other flavonoid-containing plants. The formulations and treatments can be designed to modulate the ECS so as to achieve a variety of health and wellness effects without incurring various undesirable limitations associated with cannabis. Treatments can be developed rapidly by selecting plant agents that mimic ECS effects associated with established medical agents.